Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2011 to YTD 2017 11
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deal Details 16
Venture Financing 16
Atox Bio Raises USD30 Million in Financing 16
Avraham Pharma Raises up to USD4.5 Million Financing 18
Avraham Pharma Raises USD4.5 Million in Venture Financing 19
Avraham Pharma Raises US$6 Million In Venture Financing 21
Integra Holdings Raises US$7 Million In First Round Financing 23
Avraham Pharma Secures US$3 Million In Venture Financing 24
Partnerships 25
Phytecs Enters into Agreement with Yissum Research Development 25
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 26
Accurexa Enters into Agreement with Yissum Research Development 27
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 28
Licensing Agreements 29
Therapix Biosciences Licensing Agreement with Yissum Research Development Company 29
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 30
Spherium Biomed Enters into Option Agreement with Yissum 31
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 32
Immune Pharma Enters into Licensing Agreement with Yissum 33
Kalytera Therapeutics Enters into Licensing Agreement with Yissum Research Development Company 35
Immune Pharma Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 36
BioCancell Amends Licensing Agreement With Yissum Research Development 37
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 38
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 39
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 40
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 41
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 42
BioLineRx Enters Into Licensing Agreement With Yissum Research Development For BL-7040 44
Acquisition 45
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 45
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Key Competitors 46
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Key Employees 47
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 49
Strategy And Business Planning 49
Mar 14, 2016: Yissum Forms Neteera Technologies for Remote Sensing of Biological Indicators 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Deals By Therapy Area, 2011 to YTD 2017 10
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2011 to YTD 2017 11
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Atox Bio Raises USD30 Million in Financing 16
Avraham Pharma Raises up to USD4.5 Million Financing 18
Avraham Pharma Raises USD4.5 Million in Venture Financing 19
Avraham Pharma Raises US$6 Million In Venture Financing 21
Integra Holdings Raises US$7 Million In First Round Financing 23
Avraham Pharma Secures US$3 Million In Venture Financing 24
Phytecs Enters into Agreement with Yissum Research Development 25
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 26
Accurexa Enters into Agreement with Yissum Research Development 27
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 28
Therapix Biosciences Licensing Agreement with Yissum Research Development Company 29
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 30
Spherium Biomed Enters into Option Agreement with Yissum 31
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 32
Immune Pharma Enters into Licensing Agreement with Yissum 33
Kalytera Therapeutics Enters into Licensing Agreement with Yissum Research Development Company 35
Immune Pharma Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 36
BioCancell Amends Licensing Agreement With Yissum Research Development 37
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 38
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 39
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 40
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 41
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 42
BioLineRx Enters Into Licensing Agreement With Yissum Research Development For BL-7040 44
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 45
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Competitors 46
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Employees 47
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Subsidiaries 48